ResearcherDalian University of TechnologyActive in the last 2 years
Huan Tang
Matched on ORCID iD 0000-0002-0244-3169; OpenAlex author ID A5101516053. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2024: 3 papers · 2025: 1 paper
Papers 4
- Berberine-loaded mesoporous silica nanomaterials inhibit pancreatic cancer targeting cancer stem cells. Co-author DOI 10.1093/jpp/rgaf058↗
- Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma cell line. First author DOI 10.1007/s13577-024-01100-y↗
- A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-024-56464-w↗
- Establishment and characterization of a novel multidrug-resistant pancreatic ductal adenocarcinoma cell line, PDAC-X1. Co-author DOI 10.1186/s12885-024-12588-w↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Changpeng Chai · 3 shared papers, 2024 · strength 0.55
- Paper A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-024-56464-w↗
- Paper Establishment and characterization of a novel multidrug-resistant pancreatic ductal adenocarcinoma cell line, PDAC-X1. DOI 10.1186/s12885-024-12588-w↗
- Paper Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma ce… DOI 10.1007/s13577-024-01100-y↗
- Hao Xu · 3 shared papers, 2024 · strength 0.55
- Paper A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-024-56464-w↗
- Paper Establishment and characterization of a novel multidrug-resistant pancreatic ductal adenocarcinoma cell line, PDAC-X1. DOI 10.1186/s12885-024-12588-w↗
- Paper Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma ce… DOI 10.1007/s13577-024-01100-y↗
- Wence Zhou · 3 shared papers, 2024 · strength 0.55
- Paper A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-024-56464-w↗
- Paper Establishment and characterization of a novel multidrug-resistant pancreatic ductal adenocarcinoma cell line, PDAC-X1. DOI 10.1186/s12885-024-12588-w↗
- Paper Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma ce… DOI 10.1007/s13577-024-01100-y↗
- Cheng Yu · 3 shared papers, 2024 · strength 0.55
- Paper A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-024-56464-w↗
- Paper Establishment and characterization of a novel multidrug-resistant pancreatic ductal adenocarcinoma cell line, PDAC-X1. DOI 10.1186/s12885-024-12588-w↗
- Paper Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma ce… DOI 10.1007/s13577-024-01100-y↗
- Xihuang Cao · 1 shared paper, 2025 · strength 0.27
- Yue Pan · 1 shared paper, 2025 · strength 0.27
- Bo Zhang · 1 shared paper, 2024 · strength 0.18
- Zhengfeng Wang · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.